Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
340 |
|
| Actual shortage: | 4 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 331 (97%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
50 (15%) |
|
Overdue reports |
2 (50%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| HEPARIN SODIUM INJECTION, USP | 1000UNIT | SOLUTION | Resolved | 2021-11-01 | 2022-01-19 | 148577 |
| HEPARIN SODIUM INJECTION, USP | 1000UNIT | SOLUTION | Resolved | 2022-06-08 | 2022-07-15 | 162144 |
| HEPARIN SODIUM INJECTION, USP | 1000UNIT | SOLUTION | Resolved | 2022-08-29 | 2022-09-14 | 168106 |
| HEPARIN SODIUM INJECTION, USP | 1000UNIT | SOLUTION | Resolved | 2022-08-29 | 2022-09-14 | 168109 |
| HEPARIN SODIUM INJECTION, USP | 1000UNIT | SOLUTION | Resolved | 2022-10-02 | 2023-01-26 | 170881 |
| HEPARIN SODIUM INJECTION, USP | 1000UNIT | SOLUTION | Resolved | 2022-10-03 | 2023-02-09 | 170980 |
| HEPARIN SODIUM INJECTION, USP | 1000UNIT | SOLUTION | Resolved | 2024-12-13 | 2025-01-11 | 245670 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2019-07-05 | 2019-08-02 | 88607 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2019-08-06 | 2019-08-24 | 91024 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2019-09-13 | 2019-10-02 | 93918 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2021-12-10 | 2022-01-17 | 150947 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2022-02-08 | 2022-04-13 | 154476 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Resolved | 2022-04-13 | 2023-03-01 | 158765 |
| HEPARIN SODIUM INJECTION, USP | 10000UNIT | SOLUTION | Actual shortage | 2025-04-03 | 2025-05-12 | 253985 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2024-06-10 | 2024-07-02 | 230030 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-07-30 | 2021-09-16 | 143318 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2022-02-28 | 2022-06-17 | 155735 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-01-16 | 2023-05-12 | 181142 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 10MG | SOLUTION | Resolved | 2023-08-11 | 2024-09-20 | 201627 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-07-30 | 2021-08-28 | 143321 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2